The John Paul II Stem Cell Research Institute is launching a capital campaign to locate its research activities at the BioVenture Facility in Coralville, IA.
|
|
The John Paul II Stem Cell Research Institute is launching a capital campaign to locate its research activities at the BioVenture Facility in Coralville, IA. | |
The service of humanity leads us to insist, in season and out of season, that those using the latest advances of science, especially in the
field of biotechnology, must never disregard fundamental ethical requirements by invoking a questionable solidarity which eventually leads to discriminating between one life and another and ignoring the dignity which belongs to every human being. ~Pope John Paul II
The John Paul II Stem Cell Research Institute (JP2SRI) is a non-profit research institute whose mission is to advance research and education on stem cell research in a manner consistent with a pro-life bioethics. JP2SRI is a 501(c)(3) tax-exempt public charity, as defined by the Internal Revenue Service. The Institute strictly focuses on adult and cord blood stem cell research and education. The Institute's goal is to focus on reducing the barriers of translate basic research into clinical research. JP2SRI mission is to coordinate research activities between the Institute, academia and industry and to find treatment solutions for patients with disorders that could potentially benefit from adult and umbilical cord stem cells.
JP2SRI was founded by Dr. Alan Moy. Dr. Moy is a
physician-scientist whose previous academic appointment was at the
University of Iowa College of Medicine and College of Engineering. He is
also the Founder and President of Cellular Engineering Technologies Inc., a
biotechnology company located in Iowa, which focuses on preclinical
industrial applications in adult and umbilical cord stem cell research. Dr.
Moy is currently a practicing physician in private practice and holds an
Adjunct Associate Professor position in the College of Engineering at the
University of Iowa.
The Institute represents an opportunity for pro-life individuals to support ethical-derived stem cell research consistent with pro-life values. JP2SRI DOES NOT conduct human embryonic stem cell research and does not perform therapeutic cloning or somatic cell nuclear transfer.
The majority of donations are directed toward research and education. There is low administrative overhead.
"In view of the serious ethical dilemma that the embryonic stem cell research has provoked in the medical and health fields, I am very glad to hear of your courageous decision to promote a promising area of research which has not only demonstrated a more ethical approach but also a scientifically-proven superiority of results in the treatment of many diseases as compared with embryonic stem cell research approach." ~Cardinal Alfonso Lopez Trujillo, President of the Pontificium Consilium Pro Familia to the John Paul II Stem Cell Research Institute.
"The Institute has taken on a prestigious name and we hope and pray that it will help bring together efforts that promote research, which is in full respect of and at the service of human life and dignity." ~Emmience Javier Cardinal Lozano Barragan, President of the Pontificio Consiglio Per La Pastorale Della Salute to the John Paul II Stem Cell Research Institute.